β-Catenin-Facilitated Glycolytic Reprogramming Fuels TNBC Progression: Therapeutic Blockade with XAV939.
Saved in:
| Title: | β-Catenin-Facilitated Glycolytic Reprogramming Fuels TNBC Progression: Therapeutic Blockade with XAV939. |
|---|---|
| Authors: | Umar SM; Department of Medical Oncology (Lab), Dr BRA IRCH, AIIMS, Ansari Nagar, New Delhi, India., Kahol S; Department of Pathology, AIIMS, Ansari Nagar, New Delhi, India., Mathur SR; Department of Pathology, AIIMS, Ansari Nagar, New Delhi, India., Gogia A; Department of Medical Oncology, Dr BRA IRCH, AIIMS, Ansari Nagar, New Delhi, India., Deo SVS; Department of Surgical Oncology, Dr BRA IRCH, AIIMS, Ansari Nagar, New Delhi, India., Pandey S; Department of Biostatistics, AIIMS, Ansari Nagar, New Delhi, India., Prasad CP; Department of Medical Oncology (Lab), Dr BRA IRCH, AIIMS, Ansari Nagar, New Delhi, India. |
| Source: | Technology in cancer research & treatment [Technol Cancer Res Treat] 2026 Jan-Dec; Vol. 25, pp. 15330338261425407. Date of Electronic Publication: 2026 Feb 17. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: SAGE Country of Publication: United States NLM ID: 101140941 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-0338 (Electronic) Linking ISSN: 15330338 NLM ISO Abbreviation: Technol Cancer Res Treat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41700965 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: β-Catenin-Facilitated Glycolytic Reprogramming Fuels TNBC Progression: Therapeutic Blockade with XAV939. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Umar+SM%22">Umar SM</searchLink>; Department of Medical Oncology (Lab), Dr BRA IRCH, AIIMS, Ansari Nagar, New Delhi, India.<br /><searchLink fieldCode="AU" term="%22Kahol+S%22">Kahol S</searchLink>; Department of Pathology, AIIMS, Ansari Nagar, New Delhi, India.<br /><searchLink fieldCode="AU" term="%22Mathur+SR%22">Mathur SR</searchLink>; Department of Pathology, AIIMS, Ansari Nagar, New Delhi, India.<br /><searchLink fieldCode="AU" term="%22Gogia+A%22">Gogia A</searchLink>; Department of Medical Oncology, Dr BRA IRCH, AIIMS, Ansari Nagar, New Delhi, India.<br /><searchLink fieldCode="AU" term="%22Deo+SVS%22">Deo SVS</searchLink>; Department of Surgical Oncology, Dr BRA IRCH, AIIMS, Ansari Nagar, New Delhi, India.<br /><searchLink fieldCode="AU" term="%22Pandey+S%22">Pandey S</searchLink>; Department of Biostatistics, AIIMS, Ansari Nagar, New Delhi, India.<br /><searchLink fieldCode="AU" term="%22Prasad+CP%22">Prasad CP</searchLink>; Department of Medical Oncology (Lab), Dr BRA IRCH, AIIMS, Ansari Nagar, New Delhi, India. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101140941%22">Technology in cancer research & treatment</searchLink> [Technol Cancer Res Treat] 2026 Jan-Dec; Vol. 25, pp. 15330338261425407. <i>Date of Electronic Publication: </i>2026 Feb 17. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22SAGE%22">SAGE </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101140941 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1533-0338 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215330338%22">15330338 </searchLink><i>NLM ISO Abbreviation: </i>Technol Cancer Res Treat <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41700965 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1177/15330338261425407 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 15330338261425407 Titles: – TitleFull: β-Catenin-Facilitated Glycolytic Reprogramming Fuels TNBC Progression: Therapeutic Blockade with XAV939. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Umar SM – PersonEntity: Name: NameFull: Kahol S – PersonEntity: Name: NameFull: Mathur SR – PersonEntity: Name: NameFull: Gogia A – PersonEntity: Name: NameFull: Deo SVS – PersonEntity: Name: NameFull: Pandey S – PersonEntity: Name: NameFull: Prasad CP IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2026 Jan-Dec Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1533-0338 Numbering: – Type: volume Value: 25 Titles: – TitleFull: Technology in cancer research & treatment Type: main |
| ResultId | 1 |